Company / EPS (Diluted)
Schrödinger, Inc. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.54
FY2025
5-year range
-$4.09 / $0.54
FY2021-FY2025
Trend
+125.7%
vs FY2024
Sector context
#83 of 159
Health Care
What the data says
At $0.54, Schrödinger, Inc.'s eps (diluted) ranks #83 of 159 in the Health Care sector. EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $0.54.
Based on SEC 10-K filings.
0.54 in FY2025.
Improved from $-1.42 to $0.54 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 159 in Health CareTop 52% of 159This company $0.54 Sector average $1.56
▼
-65.3% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 125.7% year-over-year.
- Ranks #83 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | +125.7% |
| FY2024 | -$2.10 | -47.9% |
| FY2023 | -$1.42 | -246.3% |
| FY2022 | -$0.41 | +90.0% |
| FY2021 | -$4.09 | +0.0% |
| FY2020 | -$4.09 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026